Clinical trial · Observational
Tunisian Lung Cancer Study
Clinical Observational Study on Tunisian Lung Cancer
NCT06934499CI-TRIAL-00090520LUNG-TUNrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pulmonary Cancer | Lung Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Diagnostic delay
- timeFrame
- Day 1
- description
- Delay to set the pulmonary cancer diagnosis
- measure
- Survival
- timeFrame
- 12 months
- description
- Overall survival
- measure
- Relapse
- timeFrame
- 12 months
- description
- Time to relapse
Secondary outcomes (1)
- measure
- Recommendation Compliance
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age more than 18 years * Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date * Informed consent Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.